Product Description

CENTRAGARD^™ 

(eprinomectin and praziquantel transdermal solution), innovative internal parasite protection for cats

CENTRAGARD is approved to treat heartworm and control three of the most common intestinal parasites of cats -- hookworms, roundworms, and tapeworms. It is the first, and only, product to protect against this spectrum of parasites in an easy-to-use transdermal formulation.

Description

Centragard® is also approved to treat and control three of the most common intestinal parasites of cats -- hookworms, roundworms, and tapeworms. It is the first, and only, product to protect against this spectrum of parasites in an easy-to-use transdermal formulation. 

Centragard® (eprinomectin and praziquantel transdermal solution) is for topical use only. Side effects may include vomiting, loss  of appetite, lethargy, and hair changes and skin reactions at the site of application.  If ingested, hypersalivation, vomiting, and lethargy may be observed. The safety of CENTRAGARD has not been tested in kittens less than 7 weeks of age or less than 1.8 lbs.

*Even indoor cats are at risk of exposure to these parasites*

IMPORTANT SAFETY INFORMATION:

CENTRAGARD (eprinomectin and praziquantel transdermal solution) is for topical use only. Side effects may include vomiting, loss  of appetite, lethargy, and hair changes and skin reactions at the site of application.  If ingested, hypersalivation, vomiting, and lethargy may be observed. The safety of CENTRAGARD has not been tested in kittens less than 7 weeks of age or less than 1.8 lbs.